Treatment of pancreatic and related cancers with 5-acyl-6,7-dihydrothieno[3,2-c]pyridines
US-9242994-B2 · Jan 26, 2016 · US
US2016136142A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016136142-A1 |
| Application number | US-201615004847-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jan 22, 2016 |
| Priority date | Mar 23, 2012 |
| Publication date | May 19, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods for inhibiting the growth of pancreatic cancer cells or other cancer cells driven by Sonic hedgehog are disclosed. The method involves exposing the cells to 5-acyl-6,7-dihydrothieno[3,2-c]pyridines of formula I
Opening claim text (preview).
1 . A method for treating a patient having an Shh-driven cancer comprising administering to said patient a therapeutically effective amount of a compound of formula: or a pharmaceutically acceptable salt thereof; wherein: R 1 and R 2 are independently hydrogen, halogen, (C 1 -C 4 )hydrocarbyl, (C 1 -C 4 )alkoxy, trifluoromethyl, trifluoromethoxy, cyano, or nitro; R 3 is (C 1…
Human Necessities · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.